SRPT vs. SPY
Compare and contrast key facts about Sarepta Therapeutics, Inc. (SRPT) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SRPT or SPY.
Correlation
The correlation between SRPT and SPY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SRPT vs. SPY - Performance Comparison
Key characteristics
SRPT:
-0.90
SPY:
0.68
SRPT:
-1.38
SPY:
0.98
SRPT:
0.80
SPY:
1.13
SRPT:
-0.79
SPY:
0.95
SRPT:
-2.08
SPY:
3.13
SRPT:
24.63%
SPY:
3.03%
SRPT:
57.35%
SPY:
13.89%
SRPT:
-98.17%
SPY:
-55.19%
SRPT:
-65.05%
SPY:
-7.62%
Returns By Period
In the year-to-date period, SRPT achieves a -48.62% return, which is significantly lower than SPY's -3.39% return. Over the past 10 years, SRPT has outperformed SPY with an annualized return of 15.97%, while SPY has yielded a comparatively lower 12.54% annualized return.
SRPT
-48.62%
-38.28%
-49.01%
-50.81%
-7.80%
15.97%
SPY
-3.39%
-3.01%
-0.13%
10.19%
19.68%
12.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SRPT vs. SPY — Risk-Adjusted Performance Rank
SRPT
SPY
SRPT vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SRPT vs. SPY - Dividend Comparison
SRPT has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.27%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.27% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
SRPT vs. SPY - Drawdown Comparison
The maximum SRPT drawdown since its inception was -98.17%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for SRPT and SPY. For additional features, visit the drawdowns tool.
Volatility
SRPT vs. SPY - Volatility Comparison
Sarepta Therapeutics, Inc. (SRPT) has a higher volatility of 36.28% compared to SPDR S&P 500 ETF (SPY) at 5.76%. This indicates that SRPT's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.